Intraoperative allogeneic blood transfusion is associated with adverse oncological outcomes in patients with surgically treated non-metastatic clear cell renal cell carcinoma

ConclusionReceipt of a PBT was an independent predictor of RFS and CSS in patients with surgically treated RCC, specifically locally advanced disease. Regarding the prognostic impact of timing or dose of PBT on survival, intraoperative BT and  ≥ 3 pRBC units were associated with adverse oncological outcomes.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research